Jianyu Li

Jianyu Li

Auto-generated profile, based on publicly available information

Jianyu Li

Chinese Institute for Brain Research Beijing (CIBR), Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Cancer Research
Verified
Journal Article
Open access
PDF file
MWMin Wu
Min Wu
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
MZMengyan Zhu
Mengyan Zhu
JLJianyu Li
Jianyu Li
QWQianghu Wang
Qianghu Wang
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow–derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM. Significance: Bone marrow–derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.



31 March 2023
Verified
Other
Open access
MWMin Wu
Min Wu
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
MZMengyan Zhu
Mengyan Zhu
JLJianyu Li
Jianyu Li
QWQianghu Wang
Qianghu Wang
Information of TAMs harboring tumor-derived mutations

31 March 2023
Verified
Other
Open access
MWMin Wu
Min Wu
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
MZMengyan Zhu
Mengyan Zhu
JLJianyu Li
Jianyu Li
QWQianghu Wang
Qianghu Wang
Macrophages phagocytose tumor cells.

31 March 2023
Verified
Other
Open access
MWMin Wu
Min Wu
LWLingxiang Wu
Lingxiang Wu
WWWei Wu
Wei Wu
MZMengyan Zhu
Mengyan Zhu
JLJianyu Li
Jianyu Li
QWQianghu Wang
Qianghu Wang
Gene signatures used for ssGSEA